Oral calcidiol is a good form of vitamin D supplementation

Clinical Cases in Mineral and Bone Metabolism

Volumn 14, Issue 2, 2017, Pages 207-208

  Biondi, Piergianni ^a   Pepe, Jessica ^a   Biamonte, Federica ^a   Occhiuto, Marco ^a   Parisi, Martina ^a   Demofonti, Chiara ^a   Baffa, Valeria ^a   Minisola, Salvatore ^a   Cipriani, Cristiana ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Calcidiol; Hypovitaminosis D; Supplementation; Vitamin D

Indexed keywords

EID: 85046372765     PISSN: 17248914     EISSN: 19713266     Source Type: Journal    
DOI: 10.11138/CCMBM/2017.14.1.207     Document Type: Review

References (15)

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81.
2. Minisola S, et al. A reappraisal of vitamin D effect on non-skeletal targets and mortality. J Endocrinol Invest. 2015;38(11):1239-41.
3. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S-6S.
4. Holick MF, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30.
5. Cipriani C, et al. Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis. J Clin Endocrinol Metab. 2013;98(7):2709-15.
6. Romagnoli E, et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab. 2008;93(8):3015-20.
7. Rossini M, et al. Guidelines for the diagnosis, prevention and management of osteoporosis. Reumatismo. 2016;68(1):1-39.
8. Russo S, et al. Metabolic changes following 500 mug monthly administration of calcidiol: a study in normal females. Calcif Tissue Int. 2011;89(3):252-7.
9. Brandi ML, Minisola S. Calcidiol [25(OH)D3]: from diagnostic marker to therapeutical agent. Curr Med Res Opin. 2013;29(11):1565-72.
10. Cianferotti L, et al. The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). Endocrine. 2015;50(1):12-26.
11. Michaud J, et al. Reduced hepatic synthesis of calcidiol in uremia. J Am Soc Nephrol. 2010;21(9):1488-97.
12. Bischoff-Ferrari HA, et al. Oral supplementation with 25(OH)D3 versus vitamin D3: effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity. J Bone Miner Res. 2012;27(1):160-9.
13. Jetter A, et al. Pharmacokinetics of oral vitamin D3 and calcifediol. Bone. 2013.
14. Meyer O, et al. Calcifediol versus vitamin D3 effects on gait speed and trunk sway in young postmenopausal women: a double-blind randomized controlled trial. Osteoporos Int. 2015;26(1):373-81.
15. Minisola S, Biondi P, Pepe J, Cipriani C, Fossi C, Giusti F, Franceschelli F, Leoncini Gz, Brandi ML. Calcifediol: perspectives for clinical applications in 2017 - control of mineral metabolism: the ADDID study. 2017.